Jan founded Health Intelligence Partners as a health care consultancy that blends more than thirty years of business and clinical experience. Health Intelligence Partners has a global focus (working in 13 countries with both health organizations and National Ministries of Health), working with clients on both short -term and long-term healthcare business strategies and solutions. Jan and Health Intelligence Partners help clients navigate the healthcare environment in order to identify and articulate value opportunities. A great deal of Jan’s focus is on consumer engagement and how it affects the decisions that the consumer makes and the actions that they take.
Prior to founding Health Intelligence Partners, Jan served as Senior Vice President and Chief Clinical Officer for CVS Caremark. During that time she was a corporate officer and on the executive team with P & L and operations experience and lead Caremark’s Medicare Part D development. Jan was also the clinical lead for CVS Caremark’s M & A as well as integration of acquired organizations. Before going to CVS Caremark, Jan had 15 years experience in healthcare administration within the health plan and academic arenas and lead operations for two population health companies.
As a veteran healthcare executive, Jan’s leadership has delivered results in a variety of settings. Jan offers her experiences and insights through her consulting agency as well as through her participation on healthcare and consumer product boards. She presently sits on healthcare focused boards including AccentCare (Chair; Compliance Committee, Compensation Committee), GNS Healthcare (Vice Chair of the Board), and Cambia Health Solutions. Jan’s consumer focused boards include Savor Health and Whiskerdocs. Jan previous board experience includes; Care Core National (Committees: Chair: Finance Past Chairperson, Compensation, Search, M&A and Strategic Directions) and Rx-Ante, which were recently sold. She also sits on numerous business and healthcare committees.
As the author of the books “Leveraging Health”, “Thirteen Common Pitfalls in Consumer Engagement”, “We Don’t Talk Anymore: A Consumers Guide to Connecting with their Doctor” and “Medical Liability for Pediatricians”, the Editor in Chief of American Journal of Pharmacy Benefit and on the editorial boards of a number of healthcare journals, Jan is considered a national health care thought leader. Jan speaks and writes on a broad range of health care issues.
Jan holds both a Doctor of Medicine degree and a Masters degree in Jurisprudence from Loyola University in Chicago, and a Certificate in Healthcare Business Administration from University of South Florida. She also holds a black belt in Six Sigma. Jan is an assistant professor at Northwestern University School of Medicine and School of Communication in Chicago, Illinois where she teaches the Engaging the Consumer in Health course.
Mark Frisse is the Accenture Professor in the Department of Biomedical Informatics at the Vanderbilt University School of Medicine. His work focuses on the intersection between health care informatics, economics, policy, and health care transformation. His service includes responsibilities coordinating informatics activities among regional hospitals and fostering effective health information exchange. His research is directed toward the potential contribution to economically sustainable health care through more effective use of informatics and information technology. As a teacher, he was the Director of the Masters in Management in Health Care Program at the Owen Graduate School of Management and lectures on health policy and technology in the Schools of Nursing and Medicine. He has also worked at with the federal government, state governments, and national bodies to develop more effective health care information technology policies and systems.
In Tennessee, Dr. Frisse led the development and oversight of a six-year federal- and state-sponsored effort to create and operate a health information exchange for the greater Memphis area. He also has over two decades of deep experience in clinician organization governance, comprehensive electronic health record systems, e-prescribing organizations, data governance, privacy policies, and care coordination. In recent years, his research has been on ONC-funded privacy research and a CMS Innovation Award focused on care coordination.
Previously, Dr. Frisse has held leadership positions at Washington University, Express Scripts, and the First Consulting Group. At Washington University, he was a principal in Project Spectrum, one of the earliest efforts to exchange data and images among hospitals. He witnessed the creation of the BJC Health System, and supported both academic and clinical health care technology initiatives.
At Express Scripts, he was Chief Medical Officer and was responsible for their Practice Patterns Science division and the DrugDigest.org consumer Web site. He worked extensively with health plans to design innovative pharmacy benefits integrated into broader health care payment approaches. While at Express Scripts, he was part of a small team that created RxHub – a collaboration among the Nation’s three largest pharmacy benefits managers. Later, he served as a board member of SureScripts, LLC – the primary infrastructure resource for e-prescribing and medication management.
At First Consulting, he led engagements in vendor selection, quality governance, physician information technology leadership development, and clinician governance. His work made him intimately acquainted both with small and large non-profit health care delivery organizations.
Dr. Frisse is a board-certified internist trained in hematology-oncology. He was trained at the University of Notre Dame (BS), Washington University (MD, MBA), and Stanford University (MS, Medical Information Science). He is on the Board of Qsource, LLC. He currently serves as an advisor to ACT.md, Atlas5D, and Cordant Health Solutions. He is a member of the National Academy of Medicine.
George Hiller founded The Hiller Pharmacy Management Group in 2009. He currently provides consulting and project management in the pharmacy benefits space working with health plans, pharmacy benefit management companies, employer groups, providers, and pharmaceutical manufacturers. Mr. Hiller’s skills and expertise include Managed Care, Medicare Part D, Medicaid, Preferred Provider Organizations, Healthcare Networks, Contracting, Product Development, Evidence-Based Formulary Development, as well as Health Economics and Outcome Research.
From March, 1993, until his retirement in May, 2009, Mr. Hiller led and directed all aspects of pharmacy benefit management for commercial business and Medicare Part D for Blue Cross and Blue Shield of Alabama. As the Executive Director of Pharmacy Benefit Management (PBM) his specific responsibilities included establishing and achieving strategies, plans, and objectives for an in-house PBM operation that eliminated the need for its former out-sourced arrangement. He was also responsible for assuring the effectiveness and quality of the in-house PBM’s operations and clinical programs. The Operational area of the PBM program included on-line claims adjudication, benefit administration, systems integration, product development, and network contracting. The Clinical Services area included drug utilization review, formulary maintenance, pharmaceutical manufacturer contracting, group reporting, and provider education.
Recent consulting engagements have been in the areas of Oncology (prostate cancer and NCCN guidelines), Hepatitis C, Immunomodulators, Multiple Sclerosis, Biologics and Bio-similar, Bone, Opioid Drug Management, and Diabetes. Specific projects have included: Pricing and contracting market assessment, value proposition development, clinical research strategy consultation, review of clinical data, study design consultation, advice and feedback on recently presented or published clinical data, and emerging trends in clinical practice relating to diagnosis and treatment.
Mr. Hiller received a Bachelor of Science in Pharmacy degree from Samford University and a Bachelors of Arts degree from Auburn University.
Dr. Andrew Kwait is currently in private practice in Salem Massachusetts, and with the CBFS/ACT programs at Eliot Community Human Services, in Danvers, Massachusetts.
Dr. Kwait earned his Bachelor of Arts degree at Washington University in St. Louis and his Medical degree at Cornell Medical College. He served as an intern in medicine at the Roosevelt Hospital/Columbia College of Physicians and Surgeons.
Dr. Kwait completed a residency in psychiatry at the Massachusetts Mental Health Center/Harvard Medical School, where he also served as chief resident. His teaching, administrative and clinical contributions for the past 36 years have been in the area of psychopharmacology, community mental health and addiction psychiatry.
Steve Mullenix joined the National Council for Prescription Drug Programs (NCPDP) in June of 2009 and currently serves as Senior Vice President Public Policy & Industry Relations. Prior to accepting his current position, Steve served as Director of Professional & Trade Relations for Covidien/Mallinckrodt Pharmaceuticals. Steve also served as Vice President of Managed Care & Professional Services during a ten year period with the national pharmacy franchise organization, Medicap Pharmacies, Inc. He is the former Executive Vice-President of the national drug utilization review and pharmacy consulting company, Q-A, Inc. Steve also served as Vice-President and Chief Operating Officer for the Iowa Pharmacy Association (IPA) and its for-profit subsidiary, PNI.
Mr. Mullenix has been an active member of numerous state, national and international pharmacy organizations including the Iowa Pharmacy Association (IPA), the American Pharmacists Association (APhA), the National Community Pharmacists Association (NCPA), the American Society of Health System Pharmacists (ASHP), the National Association of Chain Drug Stores (NACDS), the National Alliance of State Pharmacy Associations (NASPA), the Academy of Managed Care Pharmacy (AMCP), the American Society of Consultant Pharmacists (ASCP), the American Society of Association Executives (ASAE), and the International Pharmacy Federation (FIP).
Mr. Mullenix has served in a number of elected positions and appointments during his professional career. Currently, he serves on leadership and advisory boards at the Colleges of Pharmacy for both the University of Iowa and the University of Arkansas. He is also a member of the national HIT Collaborative Board and its HIT Steering Committee and is a member of the board for the Iowa Prescription Drug Corporation (IPDC) to name a few.
Mr. Mullenix began his career in community and hospital pharmacy serving for than a decade as director of pharmacy at a regional health system. Since that time he has served in a number of research, consultant, teaching and administrative capacities and now represents NCPDP in the areas of public policy, and professional and industry relations both nationally and internationally. He has authored or been quoted in a number of professional publications and is a frequent speaker on topics such as healthcare quality and safety, medication therapy management, pharmacy standards and health information technology.
Steve is a graduate of the University Of Iowa College Of Pharmacy, earning his Bachelor of Science Degree in Pharmacy in 1974.
Dr. Naum Shaparin is the Director of the Multidisciplinary Pain Program at Montefiore Medical Center and an Associate Professor of Clinical Anesthesiology and an Associate Professor of Clinical Family and Social Medicine at the Albert Einstein College of Medicine, Bronx, New York. He also serves as the Co-Director of the Regional Anesthesia and Acute Pain Medicine Fellowship Program as well as the Co-Director of three Anesthesiology Residency Rotations and three Medical Student Electives. Formerly, he was an Attending Anesthesiologist at University Hospital and Assistant Professor of Anesthesiology at the University of Medicine and Dentistry of New Jersey (now known as Rutgers) – New Jersey Medical School, Newark, New Jersey. Recently, Dr. Shaparin was voted President-elect of the Eastern Pain Association, one of the oldest and most prestigious pain societies in the United States as well as Director-at-Large of the New York Society of Interventional Pain Physicians.
Dr. Shaparin has presented over 50 abstracts at local, regional, national and international conferences. He authored a book, wrote several book chapters and published multiple articles in a peer reviewed journals. He has been awarded several investigator initiated grants from pharmaceutical and toxicology companies and received a prestigious Foundation for Anesthesia Education and Research grant to support a Medical Student Anesthesia Research Fellowship. Recently, he was selected the 2015 Research Mentor of the Year in the Department of Anesthesiology of Montefiore Medical Center/Albert Einstein College of Medicine. He was member of a research team that won Best of Category: Pain Medicine and Finalist at the International Anesthesia Research Society 2013 Meeting. Other recent awards include Best Poster at the New York and New Jersey Societies of Interventional Pain Physicians “Pain Medicine Symposium 2012: Evolving Advanced Pain Therapies” and he received a Certificate of Merit at the 9th Annual Department of Anesthesiology Academic Evening at Columbia University’s College of Physicians & Surgeons. He also mentored an anesthesiology resident whose poster received Second Place at the 2nd Annual Senior Research Day of the Department of Anesthesiology, Albert Einstein College of Medicine.
Dr. Shaparin received his Bachelor of Arts degree magna cum laude from Boston University and his Doctor of Medicine from University of Medicine and Dentistry of New Jersey – New Jersey Medical School. He completed his internship in a Transitional Year Residency Program at Overlook Hospital and Morristown Memorial Medical Center of the Atlantic Health System. He completed his residency in Anesthesiology at New York Presbyterian Hospital/Columbia University Medical Center and his fellowship in Pain Medicine at the Cleveland Clinic. Dr. Shaparin is board certified in Anesthesiology, Pain Medicine and Hospice and Palliative Medicine. In addition, Dr. Shaparin is completing his Master of Business Administration degree at New York University’s Stern School of Business (expected January 2016).
Dr. Shaparin’s research interests include patient utilization of outpatient pain services, non-opioid therapies for chronic non-malignant pain; controlled substance toxicology; the role of regional anesthesia in arteriovenous fistula creation; coccydynia (tail bone pain); neuropathic pain in scar tissue after surgical incisions; neuropathic pain related to cancer (in particular chemotherapy-induced peripheral neuralgia/neuropathy); neuropathic pain related to HIV/AIDS or HIV/AIDS medications; vulvodynia/perineal pain; post-thoracotomy pain; neck/back pain; sacroiliac joint pain; radiofrequency ablation; and neuromodulation.
George Van Antwerp is a Senior Manager within the Strategy and Operations practice of Deloitte Consulting. He is based out of the St. Louis office and is focused on pharmacy and the PBM industry.
George has worked in the PBM industry for almost 15 years. He has designed, implemented, and managed numerous consumer engagement programs around retail to mail, therapeutic substitution, and adherence and worked on solutions for condition management, opioid abuse, physician engagement, and channel management. George has worked with over 10 PBMs to help them design solutions that improve utilization of their pharmacies (retail, mail, or specialty) and led cross-functional efforts with IT and operations to evaluate and improve operating efficiency and effectiveness.
Select Consulting Engagements:
Prior joining to Deloitte, George worked with inVentiv Health in their Medical Management business focusing on oncology, diabetes, and CKD. George also worked Express Scripts where he focused on the mail order and generic solutions and had prior consulting experience with E&Y focused on the use of technology in the health plan sector. He has also worked with several start-ups in the consumer engagement and CRM space. George holds an MBA from Washington University in St. Louis and received his BS from the University of Michigan in Ann Arbor. He has been quoted in the press frequently and presented at the NBCH, PCMA, CCA, PBMI, and CBI conferences and on several AIS webinars on different pharmacy topics.
Rex Eaton was selected for Cordant’s advisory board after serving two years as a sales representative with significant success in the Midwest territory. Mr. Eaton was instrumental in the planning and opening of Cordant’s first de novo pharmacy in Indianapolis as well as the product launch of Cordant CORE in 2016. He served on the corporate strategy team and helped forge partnerships with both the Indiana Hospital Association and with several large clients in the territory. During his time as a rep, he was named the 2016 Cordant Employee of the Year, selected as a recipient of Mental Health America’s “Heroes For Recovery” award and named to the National Safety Council’s survivor advocate committee for his work at Cordant promoting the safe use and monitoring of controlled substances. Prior to working for Cordant, Mr. Eaton worked in healthcare for over 10 years as a certified registered nurse anesthetist, owned an anesthesia group and worked as a critical care nurse. He has bachelor’s degrees in telecommunication and nursing and a master’s degree in nursing from Butler University, the University of Southern Maine and Wolford College, respectively.